Drug intelligence / Profile preview

celastrol + chitosan oligosaccharide

Development stage
Preclinical
Lead developer
Zeng X
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

Celastrol-conjugated chitosan oligosaccharide (Cel-CSO) is a polymer-drug conjugate designed to improve the therapeutic profile of celastrol, a pentacyclic triterpene derived from Tripterygium wilfordii. By covalently attaching the hydrophobic celastrol to a water-soluble chitosan oligosaccharide (CSO) backbone via an amide bond, the conjugate achieves significantly higher aqueous solubility (18.6 mg/mL) and prolonged systemic circulation. In preclinical models of pancreatic cancer (BxPC-3 cells), Cel-CSO demonstrated potent anti-tumor activity, induction of apoptosis, and suppression of metastasis, while exhibiting lower hepatotoxicity and subacute toxicity compared to free celastrol.

Other names
Celastrol-conjugated chitosan oligosaccharideCelastrol-chitosan oligosaccharide conjugate
02

Targets

HSP90 (Heat shock protein 90 chaperone complex)

Beyond the preview

Go deeper on celastrol + chitosan oligosaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on celastrol + chitosan oligosaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call